Paradise™ Ultrasound Renal Denervation System for the Treatment of Hypertension

References

• Ettehad D , EmdinCA, KiranAet al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet, 387(10022), 957–967 (2016).
   PubMed Web of Science ®Google Scholar
• Noubiap JJ , NansseuJR, NyagaUF, SimePS, FrancisI, BignaJJ. Global prevalence of resistant hypertension: a meta-analysis of data from 3.2 million patients. Heart, 105(2), 98–105 (2019).
   PubMed Web of Science ®Google Scholar
• Kumbhani DJ , StegPG, CannonCPet al. Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis. Eur. Heart J., 34(16), 1204–1214 (2013).
   PubMed Web of Science ®Google Scholar
• Krum H , SchlaichMP, SobotkaPAet al. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the SYMPLICITY HTN-1 study. Lancet, 383(9917), 622–629 (2014).
   PubMed Web of Science ®Google Scholar
• Patel HC , HaywardC, VassiliouV, PatelK, HowardJP, DiMario C. Renal denervation for the management of resistant hypertension. Integr. Blood Press. Control, 8, 57–69 (2015).
   PubMedGoogle Scholar
• Rocha-Singh KJ . Renal artery denervation: a brave new frontier. Endovascular Today45–53 (2012).
   Google Scholar
• Bhatt DL , KandzariDE, O'NeillWWet al. A controlled trial of renal denervation for resistant hypertension. N. Engl. J. Med., 370(15), 1393–1401 (2014).
   PubMed Web of Science ®Google Scholar
• Kandzari DE , BhattDL, BrarSet al. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur. Heart J., 36(4), 219–227 (2015).
   PubMed Web of Science ®Google Scholar
• Mahfoud F , BakrisG, BhattDLet al. Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry. Eur. Heart J., 38(2), 93–100 (2017).
   PubMed Web of Science ®Google Scholar
• Sakakura K , RothA, LadichEet al. Controlled circumferential renal sympathetic denervation with preservation of the renal arterial wall using intraluminal ultrasound: a next-generation approach for treating sympathetic overactivity. EuroIntervention, 10(10), 1230–1238 (2015).
   PubMed Web of Science ®Google Scholar
• Sakakura K , LadichE, ChengQet al. Anatomic assessment of sympathetic peri-arterial renal nerves in man. J. Am. Coll. Cardiol., 64(7), 635–643 (2014).
   PubMed Web of Science ®Google Scholar
• Pathak A , ColemanL, RothAet al. Renal sympathetic nerve denervation using intraluminal ultrasound within a cooling balloon preserves the arterial wall and reduces sympathetic nerve activity. EuroIntervention, 11(4), 477–484 (2015).
   PubMed Web of Science ®Google Scholar
• Mauri L , KarioK, BasileJet al. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: the RADIANCE-HTN and REQUIRE clinical study designs. Am. Heart J., 195, 115–129 (2018).
   PubMed Web of Science ®Google Scholar
• Mabin T , SapovalM, CabaneV, StemmettJ, IyerM. First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension. EuroIntervention, 8(1), 57–61 (2012).
   PubMed Web of Science ®Google Scholar
• Daemen J , MahfoudF, KuckKHet al. Safety and efficacy of endovascular ultrasound renal denervation in resistant hypertension: 12-month results from the ACHIEVE study. J. Hypertens., 37(9), 1906–1912 (2019).
   PubMed Web of Science ®Google Scholar
• Azizi M , SchmiederRE, MahfoudFet al. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet, 391(10137), 2335–2345 (2018).
   PubMed Web of Science ®Google Scholar
• Azizi M , SchmiederRE, MahfoudFet al. Six-month results of treatment-blinded medication titration for hypertension control following randomization to endovascular ultrasound renal denervation or a sham procedure in the RADIANCE-HTN SOLO trial. Circulation, 139, 2542–2553 (2019).
   PubMed Web of Science ®Google Scholar
• Whelton PK , CareyRM, AronowWSet al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol., 71(19), e127–e248 (2018).
   PubMed Web of Science ®Google Scholar
• Kandzari DE , BohmM, MahfoudFet al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet, 391(10137), 2346–2355 (2018).
   PubMed Web of Science ®Google Scholar
• Böhm M , KarioK, KandzariDEet al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet, 27(20), 30554–30557 (2020).
   Google Scholar
• Mahfoud F , ManciaG, SchmiederRet al. Renal denervation in high-risk patients with hypertension. J. Am. Coll. Cardiol., 75(23), 2879–2888 (2020).
   PubMed Web of Science ®Google Scholar
• Pucci G , BattistaF, LazzariL, DominiciM, BoschettiE, SchillaciG. Progression of renal artery stenosis after renal denervation. Impact on 24-hour blood pressure. Circ. J., 78(3), 767–768 (2014).
   PubMed Web of Science ®Google Scholar
• Versaci F , TrivisonnoA, OlivieriC, CaranciF, BruneseL, PratiF. Late renal artery stenosis after renal denervation: is it the tip of the iceberg?Int. J. Cardiol., 172(3), e507–e508 (2014).
   PubMed Web of Science ®Google Scholar
• Versaci F , TrivisonnoA, OlivieriC, MagriG, CaranciF, PratiF. Is an abnormal vascular response after renal sympathetic denervation predictive of permanent damage? An unusual case of late renal artery stenosis after energy delivery. J. Endovasc. Ther., 21(2), 191–196 (2014).
   PubMed Web of Science ®Google Scholar
• Fengler K , HöllriegelR, OkonTet al. Ultrasound-based renal sympathetic denervation for the treatment of therapy-resistant hypertension: a single-center experience. J. Hypertens., 35(6), 1310–1317 (2017).
   PubMed Web of Science ®Google Scholar
• Fengler K , RommelKP, BlazekSet al. A three-arm randomized trial of different renal denervation devices and techniques in patients with resistant hypertension (RADIOSOUND-HTN). Circulation, 139(5), 590–600 (2019).
   PubMed Web of Science ®Google Scholar
• Stiermaier T , OkonT, FenglerKet al. Endovascular ultrasound for renal sympathetic denervation in patients with therapy-resistant hypertension not responding to radiofrequency renal sympathetic denervation. EuroIntervention, 12(2), e282–e289 (2016).
   PubMed Web of Science ®Google Scholar
• Al Raisi SI , PouliopoulosJ, BarryMTet al. Evaluation of lesion and thermodynamic characteristics of Symplicity and EnligHTN renal denervation systems in a phantom renal artery model. EuroIntervention, 10(2), 277–284 (2014).
   PubMed Web of Science ®Google Scholar
• Sato Y , KawakamiR, JinnouchiHet al. Comprehensive assessment of human accessory renal artery periarterial renal sympathetic nerve distribution. JACC Cardiovasc. Interv., 14(3), 304–315 (2021).
   PubMed Web of Science ®Google Scholar
• Patel HC , OteroS, MoserJBet al. A cross-sectional imaging study to identify organs at risk of thermal injury during renal artery sympathetic denervation. Int. J. Cardiol., 197, 235–240 (2015).
   PubMed Web of Science ®Google Scholar
• Lauder L , EwenS, TzafririARet al. Anatomical and procedural determinants of ambulatory blood pressure lowering following catheter-based renal denervation using radiofrequency. Cardiovasc. Revasc. Med., 19(7 Pt B), 845–851 (2018).
   PubMedGoogle Scholar
• Sakakura K , TunevS, YahagiKet al. Comparison of histopathologic analysis following renal sympathetic denervation over multiple time points. Circ. Cardiovasc. Interv., 8(2), e001813 (2015).
   PubMed Web of Science ®Google Scholar
• Sakakura K , LadichE, EdelmanERet al. Methodological standardization for the pre-clinical evaluation of renal sympathetic denervation. JACC Cardiovasc. Interv., 7(10), 1184–1193 (2014).
   PubMed Web of Science ®Google Scholar
• Williams B , ManciaG, SpieringWet al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur. Heart J., 39(33), 3021–3104 (2018).
   PubMed Web of Science ®Google Scholar
• Schmieder RE , MahfoudF, AziziMet al. European Society of Hypertension position paper on renal denervation 2018. J. Hypertens., 36(10), 2042–2048 (2018).
   PubMed Web of Science ®Google Scholar